Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal decision profile

Neuropharmacology

Neuroscience · Biochemistry, Genetics and Molecular Biology
Elsevier BVNetherlandspISSN 0028-3908eISSN 1873-7064
Checking system sharing availability.Visit homepage
Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
3.8

Journal Metrics Score 2026 · 2021–2024 window citedness 5.50.

Submission-to-acceptance
i
Submission-to-acceptanceCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED
107 daysmedian

Middle 50%: 79–140 days

100 of 100 PubMed-indexed articles · 100% coverage · 2024–2025

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
$4,050

Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iSubmission-to-acceptanceCalendar days from the received date to the accepted date in recent PubMed records. This includes editorial handling and author revisions, so it is not the time to first decision and not pure peer-review time. The radar uses a 0–100 cohort percentile with shorter observed timing plotted farther out; it does not measure review quality.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
3.82026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#80 / 2,106LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
24.5%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
1.42MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
107 daysIQR 79–140 DAYS
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
300 / yr2021–2024 AVG
Field-normalized top 10% share24.5%

294 of 1,200 works · same type, year & subfield

Field-normalized top 1% share2.2%

26 works · same type, year & subfield

Median FWCI1.42×

Above field-year expectation

Source output rank#80

of 2,106 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 1.42, so its typical recent paper runs about 42% above its field benchmark.

What does Top 10% Share mean?

24.5% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

4442016
4812017
4802018
4082019
3762020
3592021
2812022
2552023
3052024
3962025

Recent work-type mix

1,200 OpenAlex works · 2021–2024

Article91%
Paratext6.8%
Erratum1.3%
Retraction0.4%
Editorial0.3%
Review0.3%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works
KetamineMice, Inbred C57BLAlzheimer DiseaseNeuralgiaHallucinogensGastrointestinal MicrobiomeHippocampusMicrogliaAlcoholism

Leading OpenAlex topics

2021–2024 works
Neuroscience and Neuropharmacology Research151
Neurotransmitter Receptor Influence on Behavior84
Diverse Scientific and Economic Studies81
Pain Mechanisms and Treatments56
Cannabis and Cannabinoid Research53
Stress Responses and Cortisol48
Neuroendocrine regulation and behavior42
Neuroinflammation and Neurodegeneration Mechanisms40
Adenosine and Purinergic Signaling32
Tryptophan and brain disorders30
Methodology: OpenAlex snapshot 2026-08-12. FWCI, percentile badges, topics, and type mix use 1,200 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Recommended alternatives

Candidates share the leading OpenAlex topic, then subfield or field when needed, and are ranked by current Journal Metrics Score.

OpenAlex topic-neighbor model · Preview
Nature NeuroscienceTopic-neighbor alternative17.0Metrics Score455dIQR 354–601dSubmission → acceptance$$$Cost*Nature Reviews NeuroscienceTopic-neighbor alternative14.9Metrics Score—Submission → acceptance$—Cost*NeuronTopic-neighbor alternative13.3Metrics Score208dIQR 107–312dSubmission → acceptance$$$Cost*Pharmacological ResearchTopic-neighbor alternative10.8Metrics Score—Submission → acceptance$$$Cost*Trends in NeurosciencesTopic-neighbor alternative7.6Metrics Score—Submission → acceptance$$$Cost*Cellular and Molecular NeurobiologyTopic-neighbor alternative5.4Metrics Score110dIQR 81–161dSubmission → acceptance$$$Cost*

More alternative journals

Neurochemistry InternationalFrontiers in Cellular NeuroscienceCurrent Opinion in NeurobiologyFrontiers in Molecular NeuroscienceNeurobiology of DiseaseProgress in Neurobiology

* Cost is indicative only. APCs, taxes, waivers, and member discounts can change—always verify on the journal's official website.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
Cellular and Molecular NeuroscienceQ2
Molecular BiologyQ2

Considering submitting to Neuropharmacology?

Use your manuscript title to find AI-ranked journals with related recent work, fit reasons, risks, and submission strategy.

Match my manuscript →
Q2
Subfield Quartile
B2
CAS Block

Ranking and source check

#209
of 1,158 Neuroscience field journals
#1
among Q2 Neuroscience journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

View all Neuroscience journals →View Q1 Neuroscience journals →

Journal Details

OpenAlex Works
15,153
H-Index
246
Fully Open Access
No
Recent OA Works
2,800
Subject Areas
Cellular and Molecular NeuroscienceCellular and Molecular NeuroscienceMolecular BiologyMolecular Biology

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

Related Guides

Field Rankings
Archived Neuroscience Journal Selection Guide
14 min read
Field Rankings
Archived Chemistry Journal Selection Guide
14 min read
Field Rankings
Archived Biology Journal Selection Guide
14 min read
Publishing Guide
How to Choose the Right Journal for Your Research Paper
15 min read
Back to Search